Bristol Myers Squibb Co. stock rises Friday, still underperforms market
Shares of Bristol Myers Squibb Co. BMY inched 0.67% higher to $53.96 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the Dow Jones Industrial Average DJIA rising 0.81% to 42,352.75. The stock's fall snapped a six-day winning streak.
Bristol-Myers Squibb (BMY) stock shows potential for growth with recent FDA approval and strong oncology portfolio, but faces ...
Bristol-Myers Squibb Company ( NYSE:BMY ) stock is about to trade ex-dividend in two days. The ex-dividend date is ...
Prime Medicine, founded by David Liu, is finding that the path of translating scientific breakthroughs to treatments is ...
Investor's Business Daily on MSN1d
Has Consumer Products Giant Bristol-Myers Squibb Kicked Into High Gear?A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback